Near-Fatal Multiple Organ Dysfunction Syndrome Induced by Plasmodium malariae
To the Editor: We report a case of Plasmodium malariae-related multiple organ dysfunction syndrome (MODS) in a healthy immunocompetent patient. Despite extensive investigation, P. malariae was the only pathogen identifi ed. The patient's isolates had a combination of mutant alleles that could possibly explain the severity of the infection.
Five weeks after returning to France in November 2006 from Côte d'Ivoire, a 28-year-old French soldier was admitted to our surgical intensive care unit (University Hospital, Rennes, France) because of fever and MODS of suspected infectious origin. The patient had stopped taking his doxycycline for antimalarial chemoprophylaxis 3 days before his admission. During those 3 days he began to experience myalgia, fatigue, nausea, and vomiting but no fever. /L platelets, an international normalized ratio of 3.54, an activated partial thromboplastin time >180 s, and D-dimers at 25.6 μg/mL. He had severe mixed acidosis (pH 6.9 and arterial lactate 4.2 mmol/L) and acute renal failure. Blood cultures were performed. A thin-blood fi lm showed Plasmodium spp. within the red blood cells (parasitemia 0.4%). Rapid fl uid resuscitation was carried out and epinephrine was given, along with intravenous quinine (1,000 mg over 4 h, then 1,500 mg/d) and broadspectrum antimicrobial drugs (cefotaxime and ofl oxacine).
Massive acidosis developed (pH 6.61; lactate 8.8 mmol/L). A brief cardiac arrest required chest compressions and extracorporeal membrane oxygenation (ECMO) after venoarterial femoral cannulation at the bedside. Continuous venovenous hemofi ltration was started. APACHE II and SAPS 2 scores were 38 and 93, respectively. Drotrecogin-alpha (activated) was given as a 96-h infusion.
Extensive microbiologic investigations included tests for common bacteria at usual sampling sites and tests for specifi c arboviruses, Lep-tospira spp., Rickettsia spp., and parasites other than Plasmodium spp. Results were negative. P. malariae was found in the thick-blood fi lm.
The patient's cardiac and pulmonary functions stabilized over the next week. Epinephrine and ECMO were stopped. Surgical exploration of extensive lower-limb necrosis showed arterial thrombosis and Serratia marcescens infection. Amputation was necessary of the right leg at the thigh and of the left lower leg after 1 month of hospitalization. The patient was discharged from intensive care 90 days after hospital admission. One year later he was fully recovered and was using prostheses.
Almost all deaths from malaria are related to P. falciparum infection. We are unaware of previous reports of near-fatal imported P. malariae infection (1). Although we cannot defi nitively exclude bacterial co-infection, results were negative from blood cultures drawn before the fi rst antimicrobial drug dose and from all other microbiologic tests. To look for factors that might explain the unusual disease severity, we conducted additional investigations. The thick blood fi lm showed P. malariae trophozoites, schizonts, and gametocytes (285/μL). Rapid diagnostic tests were positive for pan-Plasmodium lactate dehydrogenase (pLDH) and aldolase but negative for histidinerich protein 2, which is specifi c for P. falciparum. Nested PCR with specifi c primers for P. falciparum and P. malariae, followed by sequence analysis of the SSUrRNA gene, and nested PCR, followed by sequence analysis of the pLDH gene, were negative for P. falciparum, positive for P. malariae, and negative for P. knowlesi (2) .
The patient gave written informed consent to tests for genetic polymorphisms associated with severe sepsis, coagulation disorders, and MODS (3). Several of these polymorphisms were found (Table) . He had a mannose-binding lectin (MBL) haplotype associated with low MBL levels (2 variants in the promoter region [homozygous at -550 and heterozygous at -221] and 1 in the fi rst exon [heterozygous for codon 54 mutation]) (5). He was homozygous for 4 gene polymorphisms associated with higher susceptibility or severity of severe sepsis or both and ARDS: CD14, lymphotoxin alpha, TNF-alpha, IRAK-1, and IL-6 (6-9). Furthermore, he was homozygous for a PAI-1 variant associated with decreased fi brinolysis and a higher risk for amputation, skin grafting, and death in meningococcal disease and trauma (10) . Of 11 patients with uncomplicated P. malariae whom we screened for these polymorphisms, none had such a combination of high-risk polymorphisms as did our patient. Thus, the genetic background of our patient may have contributed to the severity of P. malariae infection.
Despite extensive testing, we found no cause for this near-fatal case of MODS except P. malariae infection. An unusual combination of genetic polymorphisms may explain the extreme severity of this classically mild infection. *Except for MD-2 and MBL2, rs is the nomenclature used to describe the variants (initially described by den Dunnen and Antonarakis [4] ). TLR, toll-like receptor; MBL2, mannose-binding lectin 2; IRAK-1, interleulin-1 receptor-associated kinase; TIRAP, toll interleukin-1 receptor-associated protein; I B:, inhibitor of Nf-B; TNF, tumor necrosis factor; ACE, angiotensin-converting enzyme; MIF, macrophage migration inhibitory factor; IL, interleukin; PAI-1, plaminogen activator inhibitor-1.
Pulmonary Involvement and Leptospirosis, Greece
To the Editor: Since the leptospirosis outbreak associated with pulmonary hemorrhage in Nicaragua in 1995 (1), pulmonary manifestations of leptospirosis are often recognized in many countries; reported incidence has ranged from 20% to 70% (2-4). The severe pulmonary form of leptospirosis is accompanied by pulmonary hemorrhage, which directly results in high death rates (2, 5) . In Greece (population 11 million), leptospirosis cases in humans occur every year, usually from June to November (summer and autumn), with a peak in August. The annual incidence rate of the disease is 3 cases per 1 million population (6) (7), all samples sent to our laboratory for testing either for leptospirosis or for hantavirus infection are always tested for both (8) .
Leptospirosis was confi rmed for 123 patients, 10 (8.1%) of whom died (Table) . For 72 case-patients, paired samples were available. A commercial ELISA (Leptospira IgG/IgM, Institute Virion/Serion GmbH, Würzburg, Germany) was used to detect immunoglobulin (Ig) G and IgM against Leptospira spp.. A nested PCR, which amplifi es a 289-bp fragment of the 16S rDNA gene, was used to detect bacterial DNA (9) . IgM concentrations >20 U/mL indicated acute infection. Samples with borderline results were tested in parallel with a second sample taken from the patient 1 week later. IgG concentrations were considered only for paired samples, and a case was considered as acute leptospirosis when a >4-fold titer rise of IgG, or IgG seroconversion, was detected. When samples were taken before the sixth day of illness, initial diagnosis was achieved by PCR. In 6 of 10 fatal cases, leptospirosis was diagnosed only by PCR because antibodies were not detectable. Epidemiologic and clinical information for patients was collected from chart review, following a protocol approved by the medical school review board.
All 123 patients resided in northern Greece. Most (82.1%) were male; patients were 6-83 years of age (me-
